Lv617
3150 积分 2023-10-25 加入
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
4小时前
已完结
The antibody–drug conjugate landscape
4小时前
已完结
Exploring the next generation of antibody–drug conjugates
4小时前
已完结
Efficient Total Synthesis of 5‐Methoxypsoralen
1天前
已完结
Directly Suppressing MYC Function with Novel Alkynyl-Substituted Phenylpyrazole Derivatives that Induce Protein Degradation and Perturb MYC/MAX Interaction
1天前
已完结
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
7天前
已完结
Development of efficient docking strategies and structure-activity relationship study of the c-Met type II inhibitors
7天前
已完结
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
8天前
已完结
Selective inhibition of BET bromodomains
8天前
已完结
Phthalimide conjugation as a strategy for in vivo target protein degradation
8天前
已完结
皖公网安备34019202002308
